APRI Forecast and Technical Stock Analysis
Hold candidate since 2019-08-19
Apricus Biosciences gained 3.80% in the last trading day ( Monday, 19th Aug 2019 ), rising from $1.58 to $1.64 During the day the stock fluctuated 5.62% from a day low at $1.60 to a day high of $1.69. The price has fallen in 5 of the last 10 days , but is still up by 14.69% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 58 331 more shares were traded than the day before. In total, 155 811 shares bought and sold for approximately $255 530.00.
- 30 day high of the APRI stock price was $1.97 and low was $1.40.
- 90 day high was $2.87 and low was $1.40.
- 52 week high for Apricus Biosciences - $7.49 and low - $0.18.
Apricus Biosciences lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -40.18% during the next 3 months and, with 90% probability hold a price between $0.73 and $1.08 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday August 15, 2019, which indicates further gains until a new top pivot has been found. Apricus Biosciences has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. Apricus Biosciences holds a buy signal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $1.82. On a fall, the stock will find some support from the short-term average at $1.62. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 43 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Apricus Biosciences finds support from accumulated volume at $1.60.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.09 between high and low, or 5.62%. For the last week, the stock has had a daily average volatility of 6.91%.
Our recommended stop-loss: $1.55 (-5.68%) (This stock has high daily movements and this gives high risk. There is a buy signal from pivot bottom found 2 days ago.)
6.91 %Average volatility
Very Low Low Medium High Very High
Apricus Biosciences holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level, we recommend to hold or accumulate in this position whilst awaiting further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.
|APRI $1.64 ($0.06 3.80%)|
APRI is up $0.06 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for APRI based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the APRI analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!